Neurodegenerative disorders especially Alzheimer’s disease (AD) are significantly threatening
the public health. Acetylcholinesterase (AChE) inhibitors are compounds of great interest …

… Additionally, NPs regulated strategies mediate multiple drugs loading and targeted drug
delivery, hence enhancing drug effectiveness. Though, particular NPs can produce grave …

… , used in traditional systems of medicine (eg Chinese, Indian and European) for treatment of
… to AD treatment are discussed in this review. Compounds of potential interest for further drug …

… of Alzheimer's disease (AD) and the advantages of nanoliposomes (NLs) as drug carriers for
… ) loaded PEGylated NLs for potential AD treatment. Central composite design was applied …

… drug development in AD. All these first-line cholinesterase-inhibitors are used as symptomatic
treatments … drugs, their biological source and mode of action against Alzheimer's disease. …

… and purification of mutant versions of Alzheimer’s disease-associated amyloid β-peptides.
In this work, we have evaluated this capacity by producing and cloning genes for familial …

… of neurdegnerative disorders that include cognitive impairments, energy/fatigue, mood,
and anxiety. This part of the review series focuses specifically upon Alzheimer's Disease (AD). …

… The drawbacks of field cultivation have for a long time stimulated researchers to strive for
stable in vitro systems, which produce a desired active pharmaceutical ingredient (API) under …

Full article: Genetically engineered exosomes display RVG peptide and selectively enrich a
neprilysin variant: a potential formulation for the treatment of Alzheimer’s disease Skip to …

… Resveratrol can act as a calorie restriction mimetic, making it a good neuroprotective …
compounds and pharmaceutical compositions for preventing and treating Alzheimer's disease. …